| Courtenay L Diehl, MD | |
|
33 Chandler Ave, Batavia, NY 14020-1684 | |
| (585) 344-4700 | |
| (585) 344-5454 |
| Full Name | Courtenay L Diehl |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 33 Chandler Ave, Batavia, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306858188 | NPI | - | NPPES |
| 03124816 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | 48600 (Minnesota) | Secondary |
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | 253736-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| United Memorial Medical Center | 0547259376 | 180 |
News Archive
Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,729,772 which covers a method for using an implantable neuromodulation system in the treatment of urinary incontinence by neuromodulation or stimulation of the tibial nerve. The neuromodulation system includes a portable, external transmitter and a receiver implanted subcutaneously in the leg or ankle near the tibial nerve.
The study, which assessed the clinical records of more than 17 million adults, also identified inequalities in the risk of needing admission to ICU and the risk of COVID-19-related death.
While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.
Sen. Tom Harkin, D-Iowa, chairman of the Health, Education, Labor and Pensions Committee, said Monday that the Senate will work weekends in December to try to pass a health care reform bill, The Hill reports.
› Verified 9 days ago
| Entity Name | United Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902800352 PECOS PAC ID: 0547259376 Enrollment ID: O20040507000847 |
News Archive
Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,729,772 which covers a method for using an implantable neuromodulation system in the treatment of urinary incontinence by neuromodulation or stimulation of the tibial nerve. The neuromodulation system includes a portable, external transmitter and a receiver implanted subcutaneously in the leg or ankle near the tibial nerve.
The study, which assessed the clinical records of more than 17 million adults, also identified inequalities in the risk of needing admission to ICU and the risk of COVID-19-related death.
While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.
Sen. Tom Harkin, D-Iowa, chairman of the Health, Education, Labor and Pensions Committee, said Monday that the Senate will work weekends in December to try to pass a health care reform bill, The Hill reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Courtenay L Diehl, MD 33 Chandler Ave, Batavia, NY 14020-1684 Ph: (585) 344-4700 | Courtenay L Diehl, MD 33 Chandler Ave, Batavia, NY 14020-1684 Ph: (585) 344-4700 |
News Archive
Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,729,772 which covers a method for using an implantable neuromodulation system in the treatment of urinary incontinence by neuromodulation or stimulation of the tibial nerve. The neuromodulation system includes a portable, external transmitter and a receiver implanted subcutaneously in the leg or ankle near the tibial nerve.
The study, which assessed the clinical records of more than 17 million adults, also identified inequalities in the risk of needing admission to ICU and the risk of COVID-19-related death.
While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.
Sen. Tom Harkin, D-Iowa, chairman of the Health, Education, Labor and Pensions Committee, said Monday that the Senate will work weekends in December to try to pass a health care reform bill, The Hill reports.
› Verified 9 days ago
Dr. John C Jaeger, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30 Batavia City Ctr, Batavia, NY 14020 Phone: 585-343-6206 Fax: 585-343-5847 | |
Dr. Richard Albert Edwards Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 215 Summit St, Batavia, NY 14020 Phone: 585-344-4700 Fax: 585-345-4191 | |
Ashok P Naik, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4156 W Main Street Rd, Batavia, NY 14020 Phone: 585-344-0871 Fax: 585-344-0079 |